AMPE News and Press, Ampio Pharmaceuticals Inc. From 09/17/20

Are These Cheap Stocks To Buy Or Avoid Entirely This Month? Just because penny stocks are cheap, should you buy them? Well, if popular opinion by a set of Robinhood traders is to be believed, price is all that matters. My personal opinion is a bit different. Writing about stocks under $5 e...

Are New Highs Coming For These Penny Stocks? This week, penny stocks are experiencing a big surge of interest. Whether or not it has something to do with the massive IPOs is a question for another time. The Snowflake IPO , for example, has become one of the biggest tech IPOs in history. Whi...

Ampio Pharmaceuticals Inc. ( AMPE ) has had a long road to FDA approval for its osteoarthritis drug called Ampion. It's been 9 years and 5 clinical trials in the making, and they are in their final push for approval. There is clear evidence suggestive of approval for Ampion in osteoarthritis o...

ENGLEWOOD, Colo. , Sept. 14, 2020 /PRNewswire/ --  Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced that Michael Roshon , MD, PhD, Chie...

Are Analysts Bullish Or Bearish On These Penny Stocks? Whether you’re looking for penny stocks to buy or simply add to your watch list, I’m sure extra insight helps. Whether you get this from your own DD – due diligence – is up to you. But there are ways to gain s...

Ampio Pharmaceuticals ( AMPE +7.2% ) has announced positive results from Phase 1 trial for intravenous (IV) Ampion treatment for hospitalized COVID-19 patients receiving supplemental oxygen. More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, ...

Are These Cheap Stocks On Your Coronavirus Watch List This Week? Whether you’re looking for penny stocks under 10 cents or ones that are a bit higher in price, the same goals are in place. The whole point of trading is to make money and when it comes to penny stocks , those gains can...

ENGLEWOOD, Colo. , Sept. 9, 2020 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced positive results in early trial for intraven...

Ampio Pharmaceuticals ( AMPE +2.5% ) announces the completion of enrollment in a 10-subject Phase 1 study assessing IV Ampion in COVID-19 patients requiring supplemental oxygen. Final results should be available next week after the Safety Monitoring Committee and principal investigator...

ENGLEWOOD, Colo. , Sept. 4, 2020 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions announces the following:  Enrollment...